Sign in →

Orderable Name HCVDR Hepatitis C Virus Genotypic Antiviral Drug Resistance, Serum


Ordering Guidance


This test is intended for detection of preexisting antiviral drug resistance-associated substitutions in individuals known to be infected with hepatitis C virus (HCV) genotype 1a, 1b, or 3 (any subtype) and being considered for HCV NS3, NS5A, and NS5B inhibitor combination therapy.



Additional Testing Requirements


Prior to requesting this test, patients must have a confirmed serum or plasma hepatitis C virus (HCV) RNA level of 5000 IU/mL or higher within the preceding 30 days and a known HCV genotype result of 1a, 1b, or 3 (any subtype). The following tests are available to provide these prerequisite results:

-HCVQG / Hepatitis C Virus (HCV) RNA Quantification with Reflex to HCV Genotype, Serum

-HCVQN / Hepatitis C Virus (HCV) RNA Detection and Quantification by Real-Time Reverse Transcription-PCR, Serum

-HCVG / Hepatitis C Virus Genotype, Serum



Shipping Instructions


1. Ship specimen frozen on dry ice only.

2. If shipment will be delayed for more than 24 hours, freeze serum at -20 to -80° C before shipment, and transport on dry ice.



Necessary Information


The following 2 questions must be answered at the time of test ordering (if not ordering electronically, note the answers on the test request):

 

1. What Is the Hepatitis C Virus (HCV) RNA level in IU/mL within the last 30 days? Provide an answer using the following ranges:

- <5000

- 5000 to 1,000,000

- 1,000,001 to 10,000,000

- 10,000,001 to 100,000,000

- >100,000,000

Note: If the answer to this question is not answered or is “Unknown," testing will be canceled.

 

2. Does the patient have a known hepatitis C genotype of 1a, 1b, or 3 (any subtype)? Yes or No.

Note: If the answer to this question is "No," testing will be canceled.



Specimen Required


Supplies: Sarstedt Aliquot Tube, 5 mL (T914)

Collection Container/Tube: Serum gel

Submission Container/Tube: Plastic vial

Specimen Volume: 2.5 mL

Collection Instructions:

1. Centrifuge blood collection tube per manufacturer's instructions (eg, centrifuge and aliquot within 2 hours of collection for BD Vacutainer tubes).

2. Aliquot serum into a plastic vial.


Useful For

Detecting and identifying codon substitutions in the hepatitis C virus (HCV) NS3, NS5A, and NS5B genomic regions that confer resistance to current direct-acting antiviral drugs used for treatment of chronic hepatitis C infection due to HCV genotype 1a, 1b, or 3 (any subtype)

 

Guiding initiation or change of antiviral drug combinations for the treatment of chronic HCV infection

 

This assay should not be used as a screening test for HCV infection.

 

This test should not be ordered for HCV infection due to genotypes 2, 4, 5, or 6.

Testing Algorithm

Testing is successful only if there is sufficient hepatitis C viral (HCV) RNA present in the serum specimen (ie, 5000 IU/mL or above) in the preceding 30 days. If the HCV RNA level within the last 30 days is unknown or not provided, then this test will be canceled.

 

For more information see Chronic Hepatitis C Treatment and Monitoring Algorithm: Direct Antiviral Agent (DAA) Combination.

Method Name

Polymerase Chain Reaction (PCR) followed by Next-Generation Sequencing

Specimen Type

Serum SST

Specimen Minimum Volume

1.6 mL

Specimen Stability Information

Specimen Type Temperature Time Special Container
Serum SST Frozen (preferred) 60 days ALIQUOT TUBE
  Refrigerated  7 days ALIQUOT TUBE

Reject Due To

Gross hemolysis OK
Gross lipemia OK
Gross icterus OK

Reference Values

An interpretive report will be provided.

Day(s) Performed

Once per week

Report Available

4 to 14 days

CPT Code Information

87900

87902

87999 (if appropriate for government payers)

Forms

If not ordering electronically, complete, print, and send a Microbiology Test Request (T244) with the specimen.